Company News

Dr. Tian Wenzhi, founder and chairman of ImmuneOnco to attend the 42nd J.P. Morgan Healthcare Annual Conference and deliver a speech at the Biotech Showcase™

ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (hereinafter referred to as "ImmuneOnco", Hong Kong Stock Exchange stock code: 01541.HK) announced that the founder and chairman of ImmunueOnco, Dr. Tian, Wenzhi, will present at the 42nd Annual J.P. Morgan Healthcare Conference being held in San Francisco, CA on January 8th -11th, 2024 and deliver a speech at the Biotech Showcase™  held at the same time, comprehensively demonstrate ImmuneOnco’s innovative product pipeline and progress in clinical research and development.


Biotech Showcase™ is committed to providing private and biotechnology companies with unique opportunities to broadcast their innovative results, and to provide investors with one to one negotiations covering 24 time zones around the world, as well as keynote speeches, roadshows, conference live broadcasts, on-demand and other forms. and business leaders and senior executives from biotech and pharmaceutical companies to provide a broad networking platform.

Lecture time

January 10, 10:30 AM PT

(January 11, 2:30 am Beijing time)


Dr. Tian Wenzhi, founder, chairman and CEO of ImmuneOnco

Book a meeting

If you want to learn more about ImmuneOnco’s innovation pipeline and business development, you are welcome to make an appointment through the Biotech Showcase Partnering Platform, the official conference reservation system of the conference:

Speech recordings, PPT lecture notes and other materials can be obtained through the following link 2 hours after the meeting ends:

Meeting materials will be saved for 6 months after the meeting for review.